Peng, F., Wu, J., Bao, Y., Cheng, C., Lian, H., Wu, S., Niu, S., Yu, T. (2026). Induction chemotherapy plus camrelizumab followed by concurrent chemoradiotherapy for unresectable locally advanced esophageal squamous cell carcinoma (ImpactCRT): Long-term outcomes of a single-arm phase II trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.4059